Barbara L. Asselin

The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia

Steven E. Lipshultz, Nader Rifai, Virginia Dalton et al. · New England Journal of Medicine · 2004 · 620 citations

Medicine, Pharmacology, Pharmacotherapy +17

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz et al. · The Lancet Oncology · 2010 · 447 citations

Medicine, Pediatrics, Pharmacology +16

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Albert Moghrabi, Donna E. Levy, Barbara L. Asselin et al. · Blood · 2006 · 405 citations · Full text

Medicine, Oncology, Pediatrics +8

Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

John M. Goldberg, Lewis B. Silverman, Donna E. Levy et al. · Journal of Clinical Oncology · 2003 · 346 citations

Medicine, Oncology, Radiation Oncology +17

Comparative pharmacokinetic studies of three asparaginase preparations.

Barbara L. Asselin, John C. Whitin, D J Coppola et al. · Journal of Clinical Oncology · 1993 · 337 citations

Medicine, Pharmacokinetics, Pharmacology +13